Overweight
📧 Sign up to get email alerts when something new happens for Overweight.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) [Phase 2, Phase 3]
Phase 2/3 trial evaluating pharmacological and behavioral treatment after bariatric surgery for loss-of-control eating and obesity/overweigh…
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Update: Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating pharmacological and behavioral treatment after bariatric surgery for loss-of-control eating …
-
CLINICAL_TRIALS trial_result · 2026-07-27Clinical Trial Update: A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity [Phase 3]
Phase 3 trial update for HRS-7535 tablets in overweight or obese subjects has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities [Phase 1]
Phase 1 study results for LY3502970 in Chinese participants with overweight or obesity and weight-related comorbidities have been completed.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight [Phase 1]
Phase 1 trial comparing tablet and capsule forms of Orforglipron (LY3502970) in healthy overweight/obese participants; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants [Phase 1]
Phase 1 multiple-dose study of LY3502970 in healthy overweight/obese participants completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity [NA]
Completed clinical trial evaluating produce prescription programs for adults with overweight or obesity experiencing nutrition insecurity; r…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]
Phase 2 trial results for LY3841136 versus placebo in adults with obesity or overweight have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight [Phase 3]
Phase 3 trial update for retatrutide (LY3437943) in participants without type 2 diabetes who have obesity or overweight; study status is act…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 trial update for HS-20094 in Chinese adults with overweight or obesity has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) [Phase 3]
Phase 3 trial update for orforglipron (ATTAIN-MAINTAIN) evaluating maintenance of body weight reduction in adults with obesity or overweight…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]
Phase 3 clinical trial update for HS-20094 in Chinese adults with overweight or obesity has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight [Phase 3]
Phase 3 study of retatrutide (LY3437943) in participants with obesity or overweight has completed enrollment and is reporting results.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight [Phase 3]
A Phase 3 trial investigating the weight loss effect of NNC0487-0111 in adults with overweight/obesity and type 2 diabetes (recruiting).
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of different doses of NNC0662-0419 in overweight and obesity.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Effect of a Protein Supplementation on Body Weight and Metabolic Variables in Overweight and Obese Patients [NA]
A completed clinical trial evaluating the effect of protein supplementation on body weight and metabolic variables in overweight and obese a…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Weight Status, Resilience, and Quality of Life in Indian Children
A completed clinical trial update assessing weight status, resilience, and quality of life in Indian children.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes [Phase 3]
Phase 3 study of Eloralintide (LY3841136) in participants with obesity or overweight without type 2 diabetes is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Effect of Tai Chi and Multimodal Exercise in Overweight and Obese Women [NA]
A clinical trial from Pamukkale University assessing Tai Chi and multimodal exercise in overweight and obese women has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity [Phase 2]
Phase 2 study of Enicepatide (CT-388) in adults with obesity or overweight and at least one weight-related comorbidity has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study [NA]
This clinical trial update notes that a pilot study of carbohydrate restriction plus SGLT2 inhibition for patients with renal impairment and…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: HealthyWE: Achieving a Healthy Weight and Reducing Pain [NA]
Clinical trial update for HealthyWE evaluating weight management and pain reduction in adults with obesity or overweight. The study status i…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Bialystok Exercise Study in Diabetes [NA]
Medical University of Bialystok reports that the Bialystok Exercise Study in Diabetes has completed, evaluating exercise effects in people w…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) [Phase 4]
A Phase 4 randomized trial compares different weight-management strategies after stopping semaglutide or tirzepatide to evaluate which appro…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mobile Health Intervention for Children With Autism [NA]
A mobile health intervention trial led by Hunan Normal University for children with Autism Spectrum Disorder and obesity has completed.